Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trialsHiddo J.L. Heerspink, Tom Greene, Hocine Tighiouart et al.|The Lancet Diabetes & Endocrinology|2019Cited by 372
Natural history of parathyroid function and calcium metabolism after kidney transplantation: a single-centre studyPieter Evenepoel, Yves Vanrenterghem, Karolien Claes et al.|Nephrology Dialysis Transplantation|2004Cited by 314
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trialBrad H. Rovin, Catarina Almeida, Jonathan Barratt et al.|The Lancet|2023Cited by 264
Mycophenolate mofetil in IgA nephropathy: Results of a 3-year prospective placebo-controlled randomized studyBart Maes, Yves Vanrenterghem, Raymond Oyen et al.|Kidney International|2004Cited by 263
Influence of dietary protein supplements on the formation of bacterial metabolites in the colon.Benny Geypens, Yvo Ghoos, Martin Hiele et al.|Gut|1997Cited by 242